Should Children Get COVID-19 Shots? Separating Science From Overheated Rhetoric
Do kids need COVID shots? It's a difficult question to answer, but incendiary commentary has unnecessarily muddied the issue. Let's take a look at what we know so far.
Do kids need COVID shots? It's a difficult question to answer, but incendiary commentary has unnecessarily muddied the issue. Let's take a look at what we know so far.
The lockdowns caused by COVID-19 were a tradeoff between our actual and economic lives. The US, by and large, chose lives over economics. But rather than an either-or, could we have decided to save both? A new study suggests yes.
The New York Times (correctly) reports that a COVID pill is needed, not just a vaccine. But the paper also tells this story in its typically biased manner, implying that the government, not drug companies, discover drugs. It's a bunch of nonsense that dates back to... forever.
What do granite and bananas have in common? Radioactivity. As it turns out, radioactivity is all around us and has been for eons.
What can science tell us about fatherhood? Fathers historically have gotten a deserved but bad rap acting primarily as “hunter-gatherers” rather than as caregivers.
My Medpage feed offered up this headline: "Let's Stop Subsidizing Obesity." I thought I would find an argument over the continued financial support for sugar and corn. Then, I caught the subhead, “Government benefits should only be spent on nutritious foods.” Let’s consider their argument.
A new report out of the European Union confirms what scientists have known for decades: the weed killer glyphosate poses minimal risk to human health and the environment.
Most of the extant COVID-19 analyses have been based on national or state-level data; a more granular county-level analysis would be overwhelmed by “noise” since most counties experienced only single-digit daily caseloads. Here we used an intermediate scale, 100 counties that each include a major city. This protocol avoids the noise engendered by small populations and provides enough diversity for meaningful cross-sectional analysis.
Reforms to the U.S. drug pricing environment are required, but to improve patients’ health outcomes, reforms must be grounded in a comprehensive understanding of the current drug pricing system. Otherwise, policymakers will make things worse, not better. An important piece by ACSH advisor Dr. Robert Popovian and Wayne Winegarden, Ph.D.
A new approach to mosquito control, the disparities of the gig economy – writers edition, critical economic theory?, are lawyers circling the Wuhan lab?